Brooklyn Investment Group Trims Stock Holdings in Humana Inc. (NYSE:HUM)

Brooklyn Investment Group cut its holdings in shares of Humana Inc. (NYSE:HUM) by 17.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 610 shares of the insurance provider’s stock after selling 126 shares during the quarter. Brooklyn Investment Group’s holdings in Humana were worth $155,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV increased its stake in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares during the last quarter. Atwood & Palmer Inc. acquired a new position in Humana during the 3rd quarter worth $29,000. Ashton Thomas Securities LLC bought a new stake in shares of Humana in the 3rd quarter worth about $31,000. Your Advocates Ltd. LLP lifted its position in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the last quarter. Finally, Hollencrest Capital Management acquired a new position in Humana in the second quarter worth about $40,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Trading Up 2.5 %

Shares of HUM stock opened at $282.63 on Friday. The stock has a 50-day simple moving average of $273.81 and a 200 day simple moving average of $308.04. The stock has a market capitalization of $34.03 billion, a P/E ratio of 25.03, a P/E/G ratio of 2.02 and a beta of 0.55. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $415.73. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. On average, sell-side analysts expect that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.25%. Humana’s dividend payout ratio is currently 31.36%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Piper Sandler upped their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday. Morgan Stanley lifted their price objective on shares of Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Stephens reissued an “equal weight” rating and set a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Leerink Partners lowered shares of Humana from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $400.00 to $250.00 in a report on Wednesday, October 2nd. Finally, Barclays raised their target price on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $302.70.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.29% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.